CPT code 66770 covers nonexcisional destruction of a cyst or lesion in the iris or ciliary body using methods such as fine needle aspiration or laser. This ophthalmic procedure code is relevant nationally for ophthalmologists, surgical centers, and payers managing coverage of eye procedures where lesion ablation is preferred over excision. Understanding coding and clinical context for 66770 helps ensure accurate claim submission and consistent classification of minimally invasive ocular lesion treatments.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code represents, typical sites of service, and the clinical setting in which the procedure is performed. The publication also summarizes benchmarks and policy considerations that commonly affect reimbursement and coverage decisions for ophthalmic lesion destruction procedures, plus clinical context that clarifies when nonexcisional techniques are used compared with excisional surgery.

This summary is intended for national audiences including coding professionals, clinical administrators, and payer policy staff who need concise guidance on the clinical and billing identity of CPT code 66770 and what to expect when this procedure appears on a claim.